Literature DB >> 17934818

The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells.

Isabel Zvibel1, Dan Bar-Zohar, Yoel Kloog, Ran Oren, Shimon Reif.   

Abstract

In vivo inhibition of Ras by its antagonist farnesylthiosalicylic acid (FTS) prevents and reverses liver fibrosis in a rat model. In this study we showed the in vitro effects of Ras inhibition in a rat hepatic stellate cell line, HSC-T6. The IC(50) of FTS that inhibited PDGF-induced proliferation was 15 microM. FTS, by itself or in combination with PDGF, induced a three- to fivefold increase in the number of apoptotic stellate cells but did not induce apoptosis in cells cultured with TGFbeta1. We observed increased activity of MMP-9 and MMP-2 induced by FTS in combination with PDGF or TGFbeta. FTS, alone or in the presence of PDGF and TGFbeta, reduced collagen I mRNA expression. In conclusion, the in vivo amelioration of liver fibrosis by FTS may be explained by its ability to inhibit hepatic stellate cell proliferation, induce apoptosis and MMP-2 and MMP-9 activity, and decrease collagen I expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934818     DOI: 10.1007/s10620-007-9984-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

Authors:  A Bonacchi; P Romagnani; R G Romanelli; E Efsen; F Annunziato; L Lasagni; M Francalanci; M Serio; G Laffi; M Pinzani; P Gentilini; F Marra
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

Review 2.  Activation of hepatic stellate cells--a key issue in liver fibrosis.

Authors:  Helen L Reeves; Scott L Friedman
Journal:  Front Biosci       Date:  2002-04-01

3.  Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis.

Authors:  Erawan Borkham-Kamphorst; Jens Herrmann; Doris Stoll; Jens Treptau; Axel M Gressner; Ralf Weiskirchen
Journal:  Lab Invest       Date:  2004-06       Impact factor: 5.662

Review 4.  Signal transduction in hepatic stellate cells.

Authors:  M Pinzani; F Marra; V Carloni
Journal:  Liver       Date:  1998-02

5.  The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.

Authors:  Arif Khwaja; Claire C Sharpe; Mazhar Noor; Yoel Kloog; Bruce M Hendry
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

Review 6.  Cytokines and cellular crosstalk involved in the activation of fat-storing cells.

Authors:  A M Gressner
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

7.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Authors:  M Pinzani; L Gesualdo; G M Sabbah; H E Abboud
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 8.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells.

Authors:  Vinicio Carloni; Raffaella M S Defranco; Alessandra Caligiuri; Alessandra Gentilini; Silvia Cappadona Sciammetta; Elisabetta Baldi; Benedetta Lottini; Paolo Gentilini; Massimo Pinzani
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

10.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium.

Authors:  G D Block; J Locker; W C Bowen; B E Petersen; S Katyal; S C Strom; T Riley; T A Howard; G K Michalopoulos
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

View more
  6 in total

1.  Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid.

Authors:  Tal Oron; Galit Elad-Sfadia; Roni Haklai; Elizabeta Aizman; Eli Brazowski; Yoel Kloog; Shimon Reif
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

2.  Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line.

Authors:  Bahman Yousefi; Masoud Darabi; Behzad Baradaran; Mahmoud Shekari Khaniani; Mohammad Rahbani; Maryam Darabi; Shabnam Fayezi; Amir Mehdizadeh; Negar Saliani; Maghsod Shaaker
Journal:  Bioimpacts       Date:  2012-06-27

3.  Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cells proliferation.

Authors:  Rina Neeman; Shirley Abramovitch; Efrat Sharvit; Galit Elad-Sfadia; Roni Haklai; Yoel Kloog; Shimon Reif
Journal:  Dig Dis Sci       Date:  2014-06-19       Impact factor: 3.199

4.  Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.

Authors:  Cristian A Alvarez Rojas; Brendan R E Ansell; Ross S Hall; Robin B Gasser; Neil D Young; Aaron R Jex; Jean-Pierre Y Scheerlinck
Journal:  Parasit Vectors       Date:  2015-02-25       Impact factor: 3.876

Review 5.  A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD.

Authors:  Newaz Hossain; Pushpjeet Kanwar; Smruti R Mohanty
Journal:  Gastroenterol Res Pract       Date:  2016-02-23       Impact factor: 2.260

Review 6.  PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review).

Authors:  Hua-Zhong Ying; Qin Chen; Wen-You Zhang; Huan-Huan Zhang; Yue Ma; Song-Zhao Zhang; Jie Fang; Chen-Huan Yu
Journal:  Mol Med Rep       Date:  2017-09-27       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.